The Cigna Group, a global health company, has confirmed its previously provided outlook for the full year 2024. The company expects consolidated adjusted income from operations of at least $28.40 per share and adjusted EPS growth of at least 10% in 2025. The reaffirmation of these projections will be communicated during meetings with investors and analysts over the next few weeks.
Addressing recent speculation, The Cigna Group has stated that it is not pursuing a combination with Humana Inc. The company remains committed to its established criteria for mergers and acquisitions, considering only those that are strategically aligned, financially attractive, and have a high probability of closing.
The Cigna Group continues to prioritize shareholder value through focused execution of operational and financial targets. This includes disciplined capital deployment through dividends and share repurchases. Year-to-date, the company has repurchased $6 billion of stock, with an additional $1 billion repurchased in the fourth quarter. The company plans to actively repurchase shares in the fourth quarter of 2024 and throughout 2025. It intends to use the majority of proceeds from the sale of its Medicare businesses, expected to close in the first quarter of 2025, for share repurchases. The company still has $5.3 billion remaining on its share repurchase authorization.
The Cigna Group, listed on the New York Stock Exchange under the ticker symbol CI, is dedicated to improving the health and vitality of individuals and communities worldwide. It offers a range of products and services marketed under Evernorth Health Services, Cigna Healthcare, or its subsidiaries. With a presence in over 30 markets and jurisdictions, the company has approximately 184 million customer relationships globally.
Cautionary Note Regarding Forward-Looking Statements: This press release contains forward-looking statements based on The Cigna Group’s current expectations and projections. These statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Factors that may affect future performance include economic, regulatory, and competitive environments, as well as changes in laws or regulations. The company does not undertake any obligation to update or revise forward-looking statements, except as required by law.
For further information, please contact:
Investor Relations: Ralph Giacobbe at 860-787-7968 or [email protected]
Media Relations: Justine Sessions at 860-810-6523 or [email protected]